Vitamin D2 supplements may lower D3 levels, new research suggests

D2 can lower D3, but that doesn't mean D2 is useless
New research reveals an unexpected metabolic interaction between two common vitamin D supplement forms.
Mark

So the headline is that D2 lowers D3. But does that mean D2 is bad?

Mimi

Not necessarily. D2 still raises its own metabolite form and contributes to total vitamin D status. The surprising part is that it also appears to reduce the D3-derived form—something nobody expected.

Luke

But how much does it actually reduce it? The study says 9 to 18 nanomoles per liter depending on how you analyze it. Is that clinically meaningful?

Mimi

That's the honest answer: we don't know yet. The biochemical effect is real and reproducible across studies. Whether it matters for your actual health is still an open question.

Mark

The immune system angle sounds significant—D3 activating type I interferon and D2 not doing that.

Mimi

It does sound significant, and the gene expression changes are real. But the researchers were careful to say that changes in gene activity don't automatically mean fewer infections. You need clinical studies to prove that.

Luke

So we have a biochemical finding that's solid, an immune signaling difference that's interesting, but no proof that any of this changes health outcomes.

Mimi

Exactly. And there's another wrinkle: a 2026 review found that D2 still meaningfully affects parathyroid hormone and blood calcium, so it's not like D2 is doing nothing.

Mark

What should someone actually do with this information?

Mimi

If you're choosing a supplement, the evidence leans toward D3 for raising and maintaining vitamin D levels. But D2 isn't useless, and for some people there may be reasons to use it.

Luke

And the plant-based D3 from lichen is now available, which removes the sheep's wool objection for vegans.

Mimi

Right. The practical takeaway is that D3 appears to be the better choice for most people, but we're still waiting for the clinical studies that would tell us whether that biochemical advantage actually prevents disease.

  • A meta-analysis of 20 studies has uncovered a previously unknown effect: taking vitamin D2 supplements reduces the body's D3-derived metabolite by 9 to 18 nanomoles per liter — a finding that reframes a supplement millions take without a second thought.
  • The tension lies in a quiet biochemical rivalry: as D2 metabolites rise, the body may accelerate the clearance of D3 metabolites, suggesting the two forms compete within the body's own regulatory machinery.
  • Separate immunological research found that D3 activates type I interferon signaling — a frontline immune alarm system against viruses and bacteria — while D2 does not, raising the stakes of what once seemed like a trivial label difference.
  • Scientists are careful not to condemn D2 outright: a 2026 review confirms it still lowers parathyroid hormone and raises blood calcium, meaning it retains real biological activity even as it may undercut D3.
  • The field is now navigating toward clinical trials that can determine whether these biochemical differences translate into actual differences in illness, immunity, and long-term health — the answer that laboratory data alone cannot provide.

For decades, vitamin D2 and D3 have shared pharmacy shelves as though they were the same remedy wearing different names — but science is quietly revising that assumption. New research reveals that supplementing with D2, the form derived from fungi and yeast, may actively suppress the body's circulating levels of D3, the form human skin has always made from sunlight. The distinction carries weight because D3 appears to engage the immune system more robustly, particularly in the signaling pathways that form the body's first defense against infection. Humanity's long habit of treating these two molecules as interchangeable may have been, in the gentlest sense, a well-intentioned oversimplification.

The vitamin D aisle has long offered what felt like a simple decision, but new research suggests the choice between D2 and D3 carries more consequence than most people appreciate. Scientists have found that vitamin D2 supplementation can lower the body's circulating levels of D3 — the form the skin naturally produces from sunlight and the one that appears more effective at sustaining overall vitamin D status. The U.S. National Institutes of Health already acknowledges that D3 raises vitamin D levels more substantially and keeps them elevated longer, but this newly identified suppressive effect adds an unexpected dimension to the comparison.

The two forms differ in origin as much as in behavior. D2, or ergocalciferol, is derived from fungi or yeast exposed to ultraviolet light and has historically been the cheaper option for mass supplementation. D3, or cholecalciferol, mirrors what the body makes naturally — traditionally sourced from sheep's wool lanolin, though plant-based lichen alternatives now serve those following vegan diets. Both forms are converted by the liver into measurable metabolites, but they produce distinct versions, and it is specifically the D3-derived metabolite that researchers found declining after D2 supplementation.

A 2025 meta-analysis led by researchers at the University of Surrey and partner institutions examined 20 randomized controlled trials and found that D2 supplementation reduced D3-derived metabolite concentrations by roughly 9 to 18 nanomoles per liter. Lead researcher Emily Brown was careful to clarify that D2 does not strip vitamin D from the body — it raises its own metabolite and contributes to total vitamin D status. The surprise is that elevating one form appears to coincide with a reduction in the other, possibly because the body accelerates the breakdown of all vitamin D metabolites when concentrations rise.

The implications extend into immunology. A separate study published in Frontiers in Immunology found that D3 supplementation activated type I interferon signaling — a critical early-warning system the immune system uses to detect and respond to viral and bacterial threats — while D2 did not produce this effect. Professor Colin Smith, who led that research, noted the finding is promising but cautioned that changes in gene activity do not automatically translate into fewer illnesses in the real world.

A 2026 systematic review added important balance: D2 still meaningfully reduces parathyroid hormone and produces modest increases in blood calcium, confirming it is not biologically inert. The accumulated evidence does not condemn D2 so much as it consistently favors D3 for raising and sustaining vitamin D status. What scientists cannot yet answer is whether the reduction in circulating D3 caused by D2 supplementation produces measurable differences in disease prevention or long-term health. That question — the one that matters most to anyone standing in the supplement aisle — awaits the clinical trials still to come.

The vitamin D aisle at any pharmacy presents a simple choice: take a supplement and get your vitamin D. But new research suggests the choice matters more than most people realize. Scientists have discovered that taking vitamin D2, one of the two common forms sold as supplements, can actually lower the body's levels of vitamin D3—the form your skin naturally produces when exposed to sunlight and the one that appears more effective at maintaining overall vitamin D status.

The distinction has been largely overlooked because vitamin D2 and D3 are often treated as interchangeable. Both can raise your vitamin D levels, and both are sold in stores. But a growing body of evidence indicates they are not metabolically equivalent. The U.S. National Institutes of Health now acknowledges that D3 tends to raise vitamin D levels more substantially and keep them elevated longer than D2. The difference matters because vitamin D plays essential roles in calcium absorption, bone health, muscle function, nerve signaling, and immune response. In the UK, health authorities recommend considering 10 micrograms of vitamin D daily during the darker months when sunlight is too weak for the skin to manufacture adequate amounts.

The two forms originate differently. Vitamin D2, also called ergocalciferol, is typically produced from fungi or yeast exposed to ultraviolet light and has long been the cheaper option for mass supplementation. Vitamin D3, or cholecalciferol, is the identical form your body makes naturally. Traditionally, supplement D3 came from lanolin extracted from sheep's wool, though plant-based sources like lichen are now available—an important option for people following vegan diets. Once either form enters your body, your liver converts it into 25-hydroxyvitamin D, the form doctors measure in blood tests to assess your vitamin D status. D2 produces one version of this metabolite, D3 produces another, and it is specifically the D3-derived form that researchers found could decline after D2 supplementation.

A 2025 meta-analysis led by researchers at the University of Surrey, John Innes Centre, and Quadram Institute Bioscience examined 20 randomized controlled trials to investigate this effect. Eleven studies provided data suitable for the main analysis. The finding was striking: people taking vitamin D2 had significantly lower concentrations of the D3-derived metabolite compared to those who received no D2 supplementation. Depending on how the data were analyzed, the average reduction ranged from roughly 9 to 18 nanomoles per liter. Emily Brown, the lead researcher, emphasized that this does not mean D2 removes vitamin D from your body or that taking it is inherently harmful. D2 itself raises its own metabolite form and contributes to total vitamin D status. The surprising discovery is that increasing one form appears to coincide with a reduction in the other—a previously unknown effect.

Why this happens remains unclear. One leading hypothesis involves the body's natural regulatory mechanisms. When vitamin D metabolite concentrations rise, the body may accelerate the breakdown and removal of these compounds to maintain balance. Increasing D2 could therefore trigger faster disposal of existing D3-derived metabolites. Earlier experiments have suggested the relationship may work both directions, with D3 supplementation sometimes reducing D2-derived metabolites, though exactly how significant this balancing act is for health remains unresolved.

The research also aligns with separate findings suggesting D2 and D3 have different effects beyond simply raising vitamin D levels. A study published in Frontiers in Immunology examined how supplementation affected gene activity in blood samples. Researchers found substantial differences in how the immune system responded to each form. Vitamin D3 appeared to stimulate activity associated with type I interferon signaling—a critical immune defense system that alerts cells to developing infections and forms the body's first line of defense against viruses and bacteria. Vitamin D2 did not produce this effect. Professor Colin Smith, who led that research, noted that vitamin D3 appears to activate this key immune signaling system in ways D2 does not, potentially helping prevent pathogens from establishing infection. However, he cautioned that changes in gene activity do not automatically translate into fewer illnesses, and larger clinical studies are needed to determine what these biochemical differences mean for actual health outcomes.

More recent research has added important nuance to the picture. A 2026 systematic review examining 26 randomized trials found that D2 supplementation significantly reduced parathyroid hormone levels and produced a small increase in blood calcium, demonstrating that D2 continues to have meaningful biological effects even though it may reduce circulating D3. This matters because the reduction in D3 should not be misinterpreted as evidence that D2 is ineffective. Current NIH guidance continues to state that both forms can increase overall blood vitamin D levels. The accumulated evidence simply favors D3 for producing a larger increase and maintaining it longer. Multiple meta-analyses comparing the two forms directly have reached similar conclusions: D3 outperforms D2 at improving overall vitamin D status.

The central question scientists still cannot answer is whether the reduction in D3 that follows D2 supplementation produces meaningful differences in actual health outcomes. The randomized trial evidence strongly suggests D2 can lower circulating D3. What remains uncertain is whether that reduction matters for preventing disease or maintaining long-term health. Researchers say additional studies are needed to understand how D2 and D3 are metabolized differently, whether their effects on immune function translate into real-world health benefits, and whether D3 should become the preferred form for routine supplementation. For now, the evidence increasingly suggests that the label on your vitamin D bottle matters. Both forms can contribute to vitamin D status, but they are not metabolically interchangeable, and D3 appears to have an advantage for raising and sustaining vitamin D levels. Whether those biochemical differences ultimately translate into important differences in how healthy you stay remains the next frontier of investigation.

Vitamin D2 supplements can actually decrease levels of vitamin D3 in the body, which is a previously unknown effect of taking these supplements.
— Emily Brown, PhD Research Fellow, University of Surrey
Vitamin D3, but not vitamin D2, appears to stimulate the type I interferon signaling system in the body—a key part of the immune system that provides a first line of defense against bacteria and viruses.
— Professor Colin Smith, University of Surrey
Contact Us FAQ